Brief: Aura Biosciences FY Operating Expenses USD 112.791 Million
30/03/2026 12:00
Mar 30 (Reuters) - Aura Biosciences FY net income USD -106.191 million. FY operating income USD -112.791 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs